Leiden Academic Centre for Drug Research
The Leiden Academic Centre for Drug Research (LACDR) is responsible for the research and education in Bio-Pharmaceutical Sciences carried out at Leiden University.
Fundamental research in BioTherapeutics
The mission of the cluster BioTherapeutics focusses on the translation of cutting edge research in complex inflammatory diseases into advanced targeted therapies based on biologics, which will form a new line of drug research within the LACDR next to development of small molecules.
To the Cluster of BioTherapeutics >
Fundamental Research in Drug Target Discovery
The mission of the cluster Drug & Target Discovery is to deliver novel drug leads for targeted therapy of cancer that are safe for clinical application. Cancer is a leading cause of death and the main reason is the drug resistant phenotype of metastatic cells. The aim in the cluster is to understand the signalling wiring in metastatic cancer that drives cancer progression and that could be targeted by effective therapy.
To the Cluster of Drug Target Discovery >
Fundamental research in Systems Pharmacology
Our vision is that personalized medicine can be realized by integrating PK/PD modelling and quantitative pharmacology with metabolomics and systems biology concepts.
To the Cluster of Systems Pharmacology>
Education in Biopharmaceutical Sciences
Our education ranges the Bachelor's and Master's programmes in Bio-Pharmaceutical Sciences and the LACDR PhD-programme. We are committed to provide quality graduate experiences in a personalized environment of cutting edge research and internationally renowned supervisors.
Events04OctPhD Defence Synthesis of Phosphodiester-containing Bacterial Cell Wall Components: Teichoic Acids, Capsular Polysaccharides and Phosphatidyl Glycerol analoguesD. van der Es09NovPhD Defence High throughput microscopy of mechanism-based reporters in Drug- induced liver injurySteven Hiemstra22NovConference LACDR Fall Symposium: The 4 dimensions; in space and timeElizabeth (Liesbeth) de Lange